MALS
MCID: MDN008
MIFTS: 37

Median Arcuate Ligament Syndrome (MALS)

Categories: Cardiovascular diseases, Muscle diseases, Rare diseases

Aliases & Classifications for Median Arcuate Ligament Syndrome

MalaCards integrated aliases for Median Arcuate Ligament Syndrome:

Name: Median Arcuate Ligament Syndrome 12 20 58 44 15
Celiac Artery Compression Syndrome 12 20 58 70
Dunbar Syndrome 20 58 70
Mals 20 58
Harjola-Marable Syndrome 12
Celiac Axis Syndrome 20
Marable's Syndrome 12

Characteristics:

Orphanet epidemiological data:

58
celiac artery compression syndrome
Inheritance: Not applicable; Age of onset: Adult;

Classifications:



External Ids:

Disease Ontology 12 DOID:9892
ICD9CM 34 447.4
MeSH 44 D000074742
SNOMED-CT 67 9250002
ICD10 32 I77.4
ICD10 via Orphanet 33 I77.4
Orphanet 58 ORPHA293208
UMLS 70 C0152098 C1861783 C4020693

Summaries for Median Arcuate Ligament Syndrome

GARD : 20 Median arcuate ligament syndrome (MALS) is a rare disorder characterized by chronic, recurrent abdominal pain related to compression of the celiac artery (which supplies blood to the upper abdominal organs ) by the median arcuate ligament (a muscular fibrous band of the diaphragm). It usually presents with symptoms of abdominal pain, weight loss, and an abdominal bruit (abnormal sound of a blood vessel when blocked or narrowed). The cause is not fully understood; however, it is suspected that there could be a combination of vascular (blood supply) and neurogenic (neurological) components involved. Diagnosis is usually confirmed with imaging such as CT angiography, MRI, ultrasound, and arteriography. Surgery is currently the only treatment option and involves releasing the ligament.

MalaCards based summary : Median Arcuate Ligament Syndrome, also known as celiac artery compression syndrome, is related to peptic ulcer disease and chronic intestinal vascular insufficiency. An important gene associated with Median Arcuate Ligament Syndrome is PES1 (Pescadillo Ribosomal Biogenesis Factor 1). The drugs Aminolevulinic acid and Prilocaine have been mentioned in the context of this disorder. Affiliated tissues include skin, liver and colon.

Wikipedia : 73 In medicine, the median arcuate ligament syndrome (MALS, also known as celiac artery compression... more...

Related Diseases for Median Arcuate Ligament Syndrome

Diseases related to Median Arcuate Ligament Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 203)
# Related Disease Score Top Affiliating Genes
1 peptic ulcer disease 30.3 ATP4A ATP12A
2 chronic intestinal vascular insufficiency 30.2 CRP ATP4A ATP12A
3 superior mesenteric artery syndrome 29.6 CRP ATP4A ATP12A
4 mediastinitis 29.6 CRP ATP4A ATP12A
5 lactose intolerance 29.6 CRP ATP4A ATP12A
6 celiac disease 1 29.5 CRP ATP4A ATP12A
7 constipation 29.4 CRP ATP4A ATP12A
8 deficiency anemia 29.3 CRP ATP4A ATP12A
9 malaria, mild 11.0
10 aneurysm 10.8
11 thrombosis 10.3
12 splenic infarction 10.3
13 crohn's disease 10.3
14 aortic dissection 10.2
15 systemic lupus erythematosus 10.1
16 immune deficiency disease 10.1
17 pancreatic cancer 10.1
18 orthostatic intolerance 10.1
19 anorexia nervosa 10.1
20 ileitis 10.1
21 postural orthostatic tachycardia syndrome 10.1
22 gastric ulcer 10.1
23 respiratory failure 10.1
24 arteriovenous malformation 10.1
25 iron deficiency anemia 10.1
26 gastroparesis 10.1
27 common variable immunodeficiency 10.1
28 primary biliary cholangitis 10.1
29 hereditary hemorrhagic telangiectasia 10.1
30 telangiectasis 10.1
31 ehlers-danlos syndrome 10.1
32 duodenal ulcer 10.1
33 histoplasmosis 10.1
34 conversion disorder 10.1
35 vascular disease 10.1
36 iron metabolism disease 10.1
37 thoracic outlet syndrome 10.1
38 gastric adenocarcinoma 10.1
39 pulmonary fibrosis 10.1
40 gastritis 10.1
41 ileus 10.1
42 vasculitis 10.1
43 lupus erythematosus 10.1
44 fibrosing mediastinitis 10.1
45 retroperitoneal fibrosis 10.1
46 cerebral aneurysms 10.1
47 chronic pain 10.1
48 dysautonomia 10.1
49 syncope 10.1
50 idiopathic gastroparesis 10.1

Graphical network of the top 20 diseases related to Median Arcuate Ligament Syndrome:



Diseases related to Median Arcuate Ligament Syndrome

Symptoms & Phenotypes for Median Arcuate Ligament Syndrome

Drugs & Therapeutics for Median Arcuate Ligament Syndrome

Drugs for Median Arcuate Ligament Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 59)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aminolevulinic acid Approved Phase 4 106-60-5 137
2
Prilocaine Approved Phase 4 721-50-6 4906
3
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
4
Ethanol Approved Phase 4 64-17-5 702
5
Protoporphyrin IX Experimental Phase 4 553-12-8
6 Methyl 5-aminolevulinate Phase 4
7 Photosensitizing Agents Phase 4
8 Dermatologic Agents Phase 4
9 Sunscreening Agents Phase 4
10 Anesthetics Phase 4
11 Anti-Arrhythmia Agents Phase 4
12 Sodium Channel Blockers Phase 4
13 Diuretics, Potassium Sparing Phase 4
14 Anesthetics, Local Phase 4
15 Lidocaine, Prilocaine Drug Combination Phase 4
16
Phenytoin Approved, Vet_approved Phase 3 57-41-0 1775
17
Valproic acid Approved, Investigational Phase 3 99-66-1 3121
18 Psychotropic Drugs Phase 3
19 Neurotransmitter Agents Phase 3
20 Anticonvulsants Phase 3
21
Levetiracetam Approved Phase 2 102767-28-2 441341
22
Fluoxymesterone Approved, Illicit Phase 1, Phase 2 76-43-7 6446
23 Nootropic Agents Phase 2
24 Pharmaceutical Solutions Phase 1, Phase 2
25
Aluminum hydroxide Approved, Investigational Phase 1 21645-51-2
26
Magnesium hydroxide Approved, Investigational Phase 1 1309-42-8
27
Vitamin D Approved, Nutraceutical, Vet_approved Phase 1 1406-16-2
28 Vitamins Phase 1
29 Calciferol Phase 1
30 Calcipotriene Phase 1
31 Nutrients Phase 1
32 Micronutrients Phase 1
33 Trace Elements Phase 1
34 Gastrointestinal Agents Phase 1
35 Aluminum hydroxide, magnesium hydroxide, drug combination Phase 1
36 Integrase Inhibitors Phase 1
37 Raltegravir Potassium Phase 1
38 Anti-Retroviral Agents Phase 1
39 HIV Integrase Inhibitors Phase 1
40 Anti-Ulcer Agents Phase 1
41 Antiviral Agents Phase 1
42 Anti-HIV Agents Phase 1
43 Antacids Phase 1
44 Anti-Infective Agents Phase 1
45
Caffeine Approved 58-08-2 2519
46
Exenatide Approved, Investigational Early Phase 1 141758-74-9 15991534
47
Triamcinolone Approved, Vet_approved 124-94-7 31307
48
Cysteine Approved, Nutraceutical Early Phase 1 52-90-4 5862
49 Incretins Early Phase 1
50 Hormone Antagonists Early Phase 1

Interventional clinical trials:

(show all 47)
# Name Status NCT ID Phase Drugs
1 A Comparison of the Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Density of Ablative Laser Channel in the Treatment of Actinic Keratosis Completed NCT03731988 Phase 4 lidocaine/prilocaine (5%) application;MAL application
2 Prospective, Randomized, Controlled, Multicenter, Two-armed, Study Comparing Daylight Photodynamic Therapy Using MAL With Cryosurgery for the Treatment and Prophylaxis of Actinic Keratoses in Photodamaged Skin of the Face Completed NCT02736760 Phase 4 Daylight photodynamic therapy using Methylaminolevulinate (MAL)
3 Treatment of AKs With Daylight-PDT: Comparing Two Photosensitizers (BF-200 ALA and MAL) Completed NCT01893203 Phase 4 BF-200 ALA cream;MAL cream
4 Daylight Mediated Photodynamic Therapy for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL) Completed NCT02464709 Phase 4 Aminolevulinic Acid;Methyl 5-aminolevulinate
5 Refractory Status Epilepticus: Plasmatic Levels Monitorization Utility Completed NCT01586208 Phase 3 valproic acid (VPA)
6 A Double-blind, Multicenter, Long-term Follow-up Study to Assess Recurrence of Actinic Keratosis in Subjects Treated With Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) or Vehicle Cream in the Treatment of Thin and Moderately Thick, Non-hyperkeratotic, Non-pigmented Actinic Keratosis of the Face and Scalp When Using Daylight Photodynamic Therapy (DL-PDT), for Subjects Achieving Complete Response of Treated Lesions at Final Visit in Study RD.06.SPR.112199 Recruiting NCT04269395 Phase 3 MAL Cream;Vehicle cream
7 A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream in the Treatment of Thin and Moderately Thick, Non-hyperkeratotic, Non-pigmented Actinic Keratosis (AK) of the Face and Scalp When Using Daylight Photodynamic Therapy (DL-PDT) Active, not recruiting NCT04085367 Phase 3 MAL 16.8% cream
8 Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis. Unknown status NCT02354391 Phase 2 Ingenol mebutate Picato® and MAL PDT day 1, day 5;Ingenol mebutate Picato® day 2, 3, 4
9 Pretreatment With Ablative Fractional Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin Completed NCT03006185 Phase 2
10 Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus : An Open Randomized Study Completed NCT02920060 Phase 2 Intravenous levetiracetam;Sodium valproate
11 Methyl Aminolevulinate (MAL) and Hexaminolevulinate (HAL) Photodynamic Therapy (PDT)of Cervical Intraepithelial Lesions (SIL) - a Double-blind Dose-finding Study Completed NCT00369018 Phase 1, Phase 2 methyl aminolevulinate (MAL) and hexaminolevulinate (HAL)
12 Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne Completed NCT00594425 Phase 2 Methyl aminolevulinate (MAL) PDT
13 A Blinded, Randomized, Intra-individual, Vehicle-controlled and Multi-centre Study of Photodynamic Therapy With MAL Cream in Patients With Skin Type V or VI With Acne Vulgaris Completed NCT00673933 Phase 2 Methyl aminolevulinate (MAL) PDT
14 Daylight-mediated Photodynamic Therapy of Actinic Keratoses: a Randomized, Double-blinded Pilot Study Comparing Topical 0.2% Hexylaminolaevulinate With 16% Methylaminolaevulinate Completed NCT02149342 Phase 1, Phase 2 Hexylaminolaevulinate cream;Methylaminolaevulinate cream
15 Pretreatments of the Skin to Enhance MAL-induced Protoporphyrin IX (PpIX) Accumulation Prior to Photodynamic Therapy (PDT) Completed NCT02372370 Phase 1 MAL Control.
16 Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy With Short Incubation Time for the Treatment of Facial and Scalp Actinic Keratosis: 12-month Follow-up Results of a Randomized, Prospective, Comparative Trial Completed NCT02248298 Phase 1 2h-AFL-PDT;3h-AFL-PDT;3hr-MAL-PDT
17 A Randomized, Intra-individual, Prospective Study Comparing Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Ablative Fractional Laser Treatment in Asian Patients With Lower Extremity Bowen's Disease Completed NCT01912976 Phase 1 Er:YAG AFL-PDT;MAL-PDT
18 Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Nodular Basal Cell Carcinoma in Asian: A Prospective, Randomized Study With 12 Months Follow-up Completed NCT02018679 Phase 1
19 A Randomized, Prospective Study Comparing Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Ablative Fractional Laser Treatment for Actinic Cheilitis Completed NCT02198469 Phase 1 Er:YAG AFL-PDT;MAL-PDT
20 Efficacy of Topical Calcipotriol-assisted Ablative Fractional Laser Photodynamic Therapy for the Treatment of Actinic Keratosis: 12-month Follow-up Results of a Prospective, Randomised, Comparative Trial Completed NCT02976727 Phase 1 Topical Vitamin D (Calcipotriol) application;Placebo cream application;lidocaine/prilocaine (5%) application;MAL application
21 Efficacy of Iontophoresis-assisted Ablative Fractional Laser Photodynamic Therapy With Short Incubation Time for the Treatment of Actinic Keratosis: 12-month Follow-up Results of a Prospective, Randomised, Comparative Trial Completed NCT02670655 Phase 1 lidocaine/prilocaine (5%) application;MAL application
22 Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic Keratosis Completed NCT03325803 Phase 1 lidocaine/prilocaine (5%) application;MAL application
23 A Phase I Study for Superficial Basal Cell Carcinoma to Determine the Irradiance - Dependent Pain Threshold for Methylaminolevulinate (MAL)/PDT. Completed NCT01292668 Phase 1 methyl-5-aminolevulinate hydrochloride cream;photodynamic therapy
24 A Study to Evaluate the Effect of Staggered Dosing of a Magnesium/Aluminum Antacid on Raltegravir Pharmacokinetics in HIV-Infected Subjects on a Raltegravir-Containing Regimen Completed NCT01930045 Phase 1 Raltegravir (ISENTRESS™);MAALOX (MAL)
25 Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease: A Prospective, Randomized, Controlled Trial With 5-year Follow up Completed NCT03320447 Phase 1 lidocaine-prilocaine 5% cream application;methyl-aminolevulinate application
26 A Randomised Trial Comparing Methyl Aminolaevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: Results From a 24-month Follow-up Completed NCT02666534 Phase 1 lidocaine-prilocaine 5% cream application;methyl-aminolevulinate application
27 Endosonography For Right Side Acute Intestinal Mal-Symptoms (EFRAIM- Study) Unknown status NCT01080690
28 Effects of Constraint-induced Therapy for the Scapular Kinematics and Related to the Quality of Movement in Patients With Severe Chronic Hemiparesis Unknown status NCT02373436
29 Transepidermal Application of Metilaminolevulinate in Daylight Photodynamic Therapy in the Treatment of Photodamaged Skin Completed NCT03963765
30 Efficacy of Calcipotriol Assisted MAL-PDT Versus Conventional MAL-PDT for Actinic Keratosis: a Randomized and Controlled Study Completed NCT02878382
31 Somatic-psychosocial Multidisciplinary Care Concept for Oncologic Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): a Prospective Non-randomized Clinical Trial Completed NCT00804817
32 Comparison of a Novel Weight Bearing Cone Beam Computed Tomography (CT)Scanner Versus a Conventional CT Scanner for Measuring Patellar Instability Completed NCT02257099
33 Histological and Immunohistochemical Study of Photodamaged Skin Submitted to MAL-PDT Completed NCT00843323
34 Preliminary Study to Evaluate the Effect of an EEG-proprioceptive Neurofeedback on Cortical Excitability and Motor Function of the Upper Limb After Stroke Recruiting NCT04130711
35 Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma Recruiting NCT04185350 Early Phase 1 68Ga-NOTA-MAL-Cys39-exendin-4
36 A Phase II, Single-center STudy on the vAlue of Non-invasive Dual-Pet(18F-FES PET and 68Ga-HER2-Affibody PET)InformatiOn IN Subtype of Metastatic Breast Cancer(MBC) Recruiting NCT04758416 68Ga-HER2 affibody,18F-FDG, 18F-FES
37 Gait Training Combined With Strategies to Induce Transference to Real Life for People With Stroke Recruiting NCT04546217
38 Transcranial Electrical Stimulation for Mal de Debarquement Syndrome Active, not recruiting NCT02540616
39 Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome Active, not recruiting NCT02470377
40 Treatments of Mal de Debarquement Syndrome (MdDS) by Habituation of Velocity Storage Active, not recruiting NCT04213079
41 Translation and Transcultural Adaptation of the Arm Activity Measure (ArmA) and Motor Activity Log (MAL) to Assess Perceived Performance of the Upper Limb Use in Adults With Subacute and Chronic Stroke. F-ArmA Active, not recruiting NCT04754555
42 Dynamic 4DCT to Examine the Effect of Mal-united Distal Radius Fractures on Carpal Contact Mechanics Active, not recruiting NCT04402502
43 Effect of Moderate Weight Loss in Metabolically Abnormal Lean Subjects Active, not recruiting NCT02452567
44 WAVES: Wobble-oscillator Auditory/Visual Excitatory Stimulation for Mal de Debarquement Syndrome Not yet recruiting NCT04612010 Early Phase 1
45 Compassionate Use of Metvix® (Methyl Aminolevulinate) PDT in Subjects With Field Actinic Keratoses, Large/Multiple Superficial BCCs, or Bowen's Disease No longer available NCT00535080 Metvix (methyl aminolevulinate)
46 Transdiagnostic Interventions for Emotional Disorders Suspended NCT03855683
47 A Phase II Study Evaluating the Non-inferiority of the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy (PDT) Terminated NCT03076918

Search NIH Clinical Center for Median Arcuate Ligament Syndrome

Cochrane evidence based reviews: median arcuate ligament syndrome

Genetic Tests for Median Arcuate Ligament Syndrome

Anatomical Context for Median Arcuate Ligament Syndrome

MalaCards organs/tissues related to Median Arcuate Ligament Syndrome:

40
Skin, Liver, Colon, Pancreas

Publications for Median Arcuate Ligament Syndrome

Articles related to Median Arcuate Ligament Syndrome:

(show top 50) (show all 305)
# Title Authors PMID Year
1
Laparoscopic surgery for sigmoid colon cancer with complicated communication between the superior and inferior mesenteric arteries. 61
32790053 2021
2
Median Arcuate Ligament Syndrome with Orthostatic Intolerance: Intermediate-Term Outcomes following Surgical Intervention. 61
33338494 2021
3
Clinico-pathologic findings in patients with median arcuate ligament syndrome (celiac artery compression syndrome). 61
33798927 2021
4
Median arcuate ligament syndrome: Incidental finding or real problem? 61
33648962 2021
5
Median arcuate ligament syndrome: A clinical dilemma. 61
33648963 2021
6
Successful Interventional Radiology for Acute Median Arcuate Ligament Syndrome After Pancreaticoduodenectomy. 61
33796419 2021
7
Videolaparoscopic management of arcuate ligament syndrome in pediatric patients. 61
33507645 2021
8
Spontaneous intestinal bleeding due to pseudoaneurism of the gastroduodenal artery: case report of a rare complication to median arcuate ligament syndrome. 61
33365121 2020
9
Median arcuate ligament syndrome in a patient with frontal lobe syndrome. 61
33148590 2020
10
The "Hook" sign of median arcuate ligament syndrome on ultrasound. 61
33141260 2020
11
Long-term symptom improvement and health-related quality of life after operative management of median arcuate ligament syndrome. 61
33249207 2020
12
A case report combining Dunbar syndrome and pancreatic neuroendocrine tumor. 61
32953106 2020
13
An unusual case of median arcuate ligament syndrome with inferior mesenteric artery supply to supra-mesocolic organs: A challenge in liver transplantation. 61
33139196 2020
14
Dunbar syndrome: An unusual cause of chronic postprandial abdominal pain. 61
32774573 2020
15
A new comprehensive ultrasonic diagnostic method for celiac artery compression syndrome that hybridizes "arterial compression hook sign" and peak systolic velocity. 61
32749575 2020
16
Acute celiac artery compression syndrome with superior mesenteric artery stenosis and aortic stenosis: A rare but life-threatening complication after adult spinal deformity surgery. 61
32819791 2020
17
Holding the Secret: A Rare Case of Nausea and Vomiting Due to Ligamentous Compression of the Celiac Axis. 61
32944445 2020
18
Combined Treatment of Multiple Splanchnic Artery Aneurysms Secondary to Median Arcuate Ligament Syndrome: A Case Study and Review of the Literature. 61
32778636 2020
19
Median Arcuate Ligament Syndrome With Celiac Artery Aneurysm and Dissection. 61
32436479 2020
20
The Incidence of Chronic Mesenteric Ischemia in the Well-Defined Region of a Dutch Mesenteric Ischemia Expert Center. 61
32955192 2020
21
Abdominal Pain Associated With Anorexia Nervosa and Median Arcuate Ligament Syndrome: A Rare Condition Shadowed by a Postoperative Conversion Disorder. 61
32441203 2020
22
An Unusual Presentation of Median Arcuate Ligament Syndrome. 61
32789072 2020
23
Median arcuate ligament syndrome and upper gastrointestinal bleeding. 61
31780219 2020
24
"Step-by-step" principles of safe laparoscopic approach with technical details in "median arcuate ligament syndrome". 61
32589252 2020
25
Median arcuate ligament syndrome as a rare cause of chronic abdominal pain. 61
32680594 2020
26
Staged Treatment for an Unusual Case of Median Arcuate Ligament Syndrome Caused by Compression of the Celiac and Superior Mesenteric Arteries. 61
32027988 2020
27
Median arcuate ligament syndrome. 61
31882314 2020
28
A Ligamentous Agony: Median Arcuate Ligament Syndrome as an Under-Recognized Cause of Abdominal Pain. 61
32617247 2020
29
Renovascular hypertension secondary to renal artery compression by diaphragmatic crura. 61
32490294 2020
30
Median Arcuate Ligament Syndrome Presenting as Splenic Infarction. 61
32684034 2020
31
Robotic approach to treat Median Arcuate Ligament syndrome: a case report. 61
32440331 2020
32
Surgical Treatment of Pancreaticoduodenal Artery Aneurysm Due to Median Arcuate Ligament Syndrome for Which Intraoperative Doppler Ultrasonography Was BeneficialA Case Report. 61
32433413 2020
33
Robotic Surgery for Median Arcuate Ligament Syndrome. 61
32518479 2020
34
An Atypical Presentation of Median Arcuate Ligament Syndrome. 61
32300508 2020
35
CT imaging findings of abdominopelvic vascular compression syndromes: what the radiologist needs to know. 61
32185572 2020
36
Intravascular ultrasound-guided laparoscopic division of the median arcuate ligament. 61
32154471 2020
37
Laparoscopic therapy of the coeliac artery compression syndrome: a critical analysis of the current standard procedure. 61
31508996 2020
38
Metachronous rupture of a residual pancreaticoduodenal aneurysm after release of the median arcuate ligament: a case report. 61
32016595 2020
39
An unusual cause of epigastric pain and diaphoresis. 61
32140607 2020
40
Hybrid Laparoscopic and Endovascular Treatment for Median Arcuate Ligament Syndrome: Case Report and Review of Literature. 61
31622755 2020
41
Aneurysm of the hepatic artery caused by median arcuate ligament syndrome (MALS). 61
31960685 2020
42
Interprofessional Management of Median Arcuate Ligament Syndrome (Dunbar Syndrome) Related to Lumbar Lordosis and Hip Dysplasia: A Patient's Perspective. 61
32665927 2020
43
Treatment of median arcuate ligament syndrome: outcome of laparoscopic approach. 61
32428132 2020
44
The Roles of Celiac Trunk Angle and Vertebral Origin in Median Arcuate Ligament Syndrome. 61
32023842 2020
45
Assessment of celiac artery compression using color-coded duplex sonography. 61
32675404 2020
46
Perioperative Microcirculatory Changes Detected with Gastroscopy Assisted Laser Doppler Flowmetry and Visible Light Spectroscopy in Patients with Median Arcuate Ligament Syndrome. 61
32982262 2020
47
Spontaneous Retroperitoneal Hemorrhage Secondary to Chronic Celiac Axis Compression Treated with Embolization Utilizing Cone Beam CT. 61
32832185 2020
48
Laparoscopic management of celiac artery compression syndrome: A case report. 61
33011657 2020
49
Insight into Dunbar syndrome: color-Doppler ultrasound findings and literature review. 61
31925730 2020
50
Factors Associated with Symptomology of Celiac Artery Compression and Outcomes following Median Arcuate Ligament Release. 61
31449931 2020

Variations for Median Arcuate Ligament Syndrome

Expression for Median Arcuate Ligament Syndrome

Search GEO for disease gene expression data for Median Arcuate Ligament Syndrome.

Pathways for Median Arcuate Ligament Syndrome

GO Terms for Median Arcuate Ligament Syndrome

Biological processes related to Median Arcuate Ligament Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 proton transmembrane transport GO:1902600 9.37 ATP4A ATP12A
2 potassium ion import across plasma membrane GO:1990573 9.32 ATP4A ATP12A
3 cellular sodium ion homeostasis GO:0006883 9.26 ATP4A ATP12A
4 sodium ion export across plasma membrane GO:0036376 9.16 ATP4A ATP12A
5 cellular potassium ion homeostasis GO:0030007 8.96 ATP4A ATP12A
6 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 8.62 ATP4A ATP12A

Molecular functions related to Median Arcuate Ligament Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 9.16 ATP4A ATP12A
2 potassium-transporting ATPase activity GO:0008556 8.96 ATP4A ATP12A
3 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP4A ATP12A

Sources for Median Arcuate Ligament Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....